Northwest Biotherapeutics Inc (OTCQB:NWBO)

0.188
Delayed Data
As of 11:40am ET
 -0.0015 / -0.79%
Today’s Change
0.14
Today|||52-Week Range
0.40
-20.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues68.0K88.0K148.0K32.0K
 
 
 
 
 
Depreciation And Amortization56.0K44.0K41.0K298.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses11.9M10.7M14.2M17.7M
 
 
 
 
 
Research And Development5.0M5.5M9.7M13.3M
 
 
 
 
 
Total Operating Expenses12.0M10.8M14.3M18.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.9M-10.7M-14.1M-18.0M
 
 
 
 
 
Extraordinary Credit1.4M6.5M0.000.00
 
 
 
Extraordinary Charge-1.5M-7.0M-9.2M-7.6M
 
 
 
 
 
Interest Expense On Debt1.2M1.3M1.2M1.9M
 
 
 
 
 
Other Expenses574.0K2.3M1.3M420.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.6M-10.3M-23.3M-27.0M
 
 
 
 
 
Preferred Dividend0.000.000.00-1.3M
 
 
Net Income-12.6M-10.3M-23.3M-27.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS161.5M208.5M281.5M328.9M
 
 
 
 
 
Shares To Calculate EPS Diluted161.5M208.5M281.5M328.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$0.05-$0.08-$0.10
 
 
 
 
 
EPS Diluted-$0.08-$0.05-$0.08-$0.10